Abiopharma

New Form SCHEDULE 13G - Tarsus Pharmaceuticals, Inc. Filed: 2025-07-28 AccNo: 0001172661-25-002747 Size: 11 KB

New Form 6-K - BetterLife Pharma Inc. Filed: 2025-07-28 AccNo: 0001477932-25-005272 Size: 42 KB

NRC Health Announces Second Quarter 2025 Results

RCKT INVESTOR DEADLINE: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit

New Form 8-K - Qualigen Therapeutics, Inc. Filed: 2025-07-28 AccNo: 0001641172-25-021174 Size: 863 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclosure Item 8.01: Other …

New Form F-3ASR - Alvotech Filed: 2025-07-28 AccNo: 0000930413-25-002271 Size: 551 KB

New Form 144 - Medpace Holdings, Inc. Filed: 2025-07-28 AccNo: 0001959173-25-004786 Size: 4 KB

New Form 4 - THERMO FISHER SCIENTIFIC INC. Filed: 2025-07-28 AccNo: 0000097745-25-000097 Size: 4 KB

New Form 4 - Processa Pharmaceuticals, Inc. Filed: 2025-07-28 AccNo: 0000897069-25-001223 Size: 5 KB

New Form 144 - GILEAD SCIENCES, INC. Filed: 2025-07-28 AccNo: 0001950047-25-005228 Size: 6 KB

New Form 6-K - Cellectis S.A. Filed: 2025-07-28 AccNo: 0001171843-25-004747 Size: 11 KB

New Form 144 - Medpace Holdings, Inc. Filed: 2025-07-28 AccNo: 0001969223-25-000533 Size: 4 KB

Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering

New Form 4 - Processa Pharmaceuticals, Inc. Filed: 2025-07-28 AccNo: 0000897069-25-001221 Size: 5 KB

New Form 4 - Processa Pharmaceuticals, Inc. Filed: 2025-07-28 AccNo: 0000897069-25-001219 Size: 5 KB